These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9419183)

  • 1. Enhanced control of an outbreak of Mycoplasma pneumoniae pneumonia with azithromycin prophylaxis.
    Klausner JD; Passaro D; Rosenberg J; Thacker WL; Talkington DF; Werner SB; Vugia DJ
    J Infect Dis; 1998 Jan; 177(1):161-6. PubMed ID: 9419183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia.
    Hyde TB; Gilbert M; Schwartz SB; Zell ER; Watt JP; Thacker WL; Talkington DF; Besser RE
    J Infect Dis; 2001 Mar; 183(6):907-12. PubMed ID: 11237807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.
    Ríos AM; Fonseca-Aten M; Mejías A; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Ramilo O; Hardy RD
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3970-3. PubMed ID: 16127085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous versus intermittent azithromycin administration for treatment of Mycoplasma pneumonia-induced pneumonia: effects and drug resistance in rats].
    Wei W
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Aug; 30(8):1918-9, 1922. PubMed ID: 20813702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin sequential therapy plus inhaled terbutaline for Mycoplasma Pneumoniae pneumonia in children: a systematic review and meta-analysis.
    Sheng Y; Liang Y; Zhao C; Kang D; Liu X
    BMC Infect Dis; 2024 Jun; 24(1):653. PubMed ID: 38944667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effect of sequential therapy with azithromycin in children mycoplasma pneumoniae pneumonia.
    Wang J; Yang C
    Pak J Pharm Sci; 2018 Jul; 31(4(Special)):1649-1652. PubMed ID: 30203754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State.
    Waring AL; Halse TA; Csiza CK; Carlyn CJ; Arruda Musser K; Limberger RJ
    J Clin Microbiol; 2001 Apr; 39(4):1385-90. PubMed ID: 11283060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of a
    Gdalevich M; Haas EJ; Dukhan L; Katz M; Zelenski V; Moran-Gilad J
    Front Public Health; 2017; 5():366. PubMed ID: 29404316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.
    Dumke R; Stolz S; Jacobs E; Juretzek T
    Int J Infect Dis; 2014 Dec; 29():197-9. PubMed ID: 25449256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia.
    Schönwald S; Barsić B; Klinar I; Gunjaca M
    Scand J Infect Dis; 1994; 26(6):706-10. PubMed ID: 7747094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled clinical trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population.
    Gray GC; Witucki PJ; Gould MT; Bell SJ; Hiliopoulos KM; McKeehan JA; Fuller JM; Barrozo CP; Hudspeth MK; Smith TC; Ledbetter EK; Wallace MR
    Clin Infect Dis; 2001 Oct; 33(7):983-9. PubMed ID: 11528569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macrolide resistance in Mycoplasma pneumoniae by recurrence and extended illness].
    Uldum SA; Amberg P; Jensen JS
    Ugeskr Laeger; 2012 Mar; 174(11):730-1. PubMed ID: 22409896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying network theory to epidemics: control measures for Mycoplasma pneumoniae outbreaks.
    Ancel Meyers L; Newman ME; Martin M; Schrag S
    Emerg Infect Dis; 2003 Feb; 9(2):204-10. PubMed ID: 12603991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An outbreak of pneumococcal pneumonia among military personnel at high risk: control by low-dose azithromycin postexposure chemoprophylaxis.
    Sanchez JL; Craig SC; Kolavic S; Hastings D; Alsip BJ; Gray GC; Hudspeth MK; Ryan MA
    Mil Med; 2003 Jan; 168(1):1-6. PubMed ID: 12546236
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Krafft C; Christy C
    Pediatr Rev; 2020 Jan; 41(1):12-19. PubMed ID: 31894069
    [No Abstract]   [Full Text] [Related]  

  • 17. Outbreak of Mycoplasma pneumoniae at a military academy.
    Zhang X; Han MN; Dong JH; Li XX; Hu XY; Wang Z; Qin EQ; Li J; Tan JY; Wang FS; Huang L
    Mil Med Res; 2020 Dec; 7(1):60. PubMed ID: 33272310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.
    Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K
    Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycoplasma pneumoniae-associated mucositis: a case report].
    Yin J; Li X; Liu L; Hu J; Li C
    Zhonghua Er Ke Za Zhi; 2014 May; 52(5):399-400. PubMed ID: 24969943
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical efficacy enhancement of a Chinese herbal injection in the treatment of mycoplasma pneumonia in children: A protocol of randomized controlled trial.
    Wang M; Li H; Yang J; Wang M; Liu J
    Medicine (Baltimore); 2021 Mar; 100(12):e25135. PubMed ID: 33761679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.